Asthma inhaler technique & training
Asthma inhaler technique & training
Get access to exclusive content and news updates:
Dr Stephanie Korn
Dr. Stephanie Korn is the Head of the Clinical Research Centre IKF Pneumologie Mainz, Germany.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com
The content of this website has been developed by Napp Pharmaceuticals Limited for UK healthcare professionals only. Napp is responsible for the content of this website and is also the copyright owner/authorised user of the content.
UK-RZF-2400060 | DOP: March 2024
For Healthcare Professionals: Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Napp Pharmaceuticals Limited at drugsafetyUKandROI@mundipharma.com.
For General Public: If you experience any side-effects, talk to your doctor, nurse or pharmacist. This includes any possible side-effects not listed in the package leaflet. You can also report side-effects directly via the Yellow Card scheme at www.mhra.gov.uk/yellowcard. By reporting side-effects you can help provide more information on the safety of this medicine.
For Healthcare Professionals: Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Napp Pharmaceuticals Limited at drugsafetyUKandROI@mundipharma.com.
For General Public: If you experience any side-effects, talk to your doctor, nurse or pharmacist. This includes any possible side-effects not listed in the package leaflet. You can also report side-effects directly via the Yellow Card scheme at www.mhra.gov.uk/yellowcard. By reporting side-effects you can help provide more information on the safety of this medicine.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com
Copyright 2021 Napp Pharmaceuticals. All Rights Reserved. | JOB CODE: UK-ADI-2300001 | Prepared: December 2023
Would you like to register?
Napp Academy offers free medical education. Downloadable HCP Resources in a variety of therapy areas. Sign up for latest events and webinars.
Your browser is not supported.
To view this content, please use one of the following browsers:
This feature is not available in mobile. Use Tablet/Computer to access it.
Dr. Stephanie Korn is the Head of the Clinical Research Centre IKF Pneumologie Mainz, Germany.
Prof Hans-Joachim Kabitz in this video focuses on appropriate asthma therapy introduction and optimisation of inhaled therapy in severe asthma.
Specialist in internal medicine and pneumology with additional qualification in internal intensive care medicine, Klinikum Konstanz, Germany.
Prof Hans-Joachim Kabitz in this video discusses Maintenance and Reliever Therapy (MART) vs Maintenance in asthma management.
Specialist in internal medicine and pneumology with additional qualification in internal intensive care medicine, Klinikum Konstanz, Germany.
Dr Stephanie Korn in this video focuses on the Pharmacological management of asthma in adults.
Dr. Stephanie Korn is the Head of the Clinical Research Centre IKF Pneumologie Mainz, Germany.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com.